Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells

Anthracyclines (such as doxorubicin or daunorubicin) are among the most effective anticancer drugs, but their usefulness is hampered by the risk of irreversible cardiotoxicity. Dexrazoxane (ICRF-187) is the only clinically approved cardioprotective agent against anthracycline cardiotoxicity. Its act...

Descripción completa

Detalles Bibliográficos
Autores principales: Vavrova, Anna, Jansova, Hana, Mackova, Eliska, Machacek, Miloslav, Haskova, Pavlina, Tichotova, Lucie, Sterba, Martin, Simunek, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792022/
https://www.ncbi.nlm.nih.gov/pubmed/24116135
http://dx.doi.org/10.1371/journal.pone.0076676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792022/
https://www.ncbi.nlm.nih.gov/pubmed/24116135
http://dx.doi.org/10.1371/journal.pone.0076676

Ejemplares similares